RMFCX
Price
$53.56
Change
+$3.33 (+6.63%)
Updated
Apr 9 closing price
Net Assets
92.19B
YAFIX
Price
$17.92
Change
+$1.03 (+6.10%)
Updated
Apr 9 closing price
Net Assets
2.34B
Ad is loading...

RMFCX vs YAFIX

Header iconRMFCX vs YAFIX Comparison
Open Charts RMFCX vs YAFIXBanner chart's image
American Funds American Mutual R3
Price$53.56
Change+$3.33 (+6.63%)
VolumeN/A
Net Assets92.19B
AMG Yacktman Focused I
Price$17.92
Change+$1.03 (+6.10%)
VolumeN/A
Net Assets2.34B
RMFCX vs YAFIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RMFCX vs. YAFIX commentary
Apr 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RMFCX is a Buy and YAFIX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 92.2B vs. YAFIX (2.34B). YAFIX pays higher dividends than RMFCX: YAFIX (2.01) vs RMFCX (1.34). RMFCX was incepted earlier than YAFIX: RMFCX (23 years) vs YAFIX (13 years). YAFIX (1.06) is less costly to investors than RMFCX (0.91). RMFCX is a more actively managed with annual turnover of: 31.00 vs. YAFIX (4.00). RMFCX has a lower initial minimum investment than YAFIX: RMFCX (250) vs YAFIX (100000). RMFCX annual gain was more profitable for investors over the last year : -4.43 vs. YAFIX (-20.56). RMFCX return over 5 years is better than : 45.42 vs. YAFIX (15.15).
RMFCXYAFIXRMFCX / YAFIX
Total Expense Ratio0.911.0686%
Annual Report Gross Expense Ratio0.911.0686%
Fund Existence23 years13 years-
Gain YTD-7.697-8.20794%
Front LoadN/AN/A-
Min. Initial Investment2501000000%
Min. Initial Investment IRAN/AN/A-
Net Assets92.2B2.34B3,947%
Annual Yield % from dividends1.342.0167%
Returns for 1 year-4.43-20.5622%
Returns for 3 years-0.65-14.884%
Returns for 5 years45.4215.15300%
Returns for 10 years46.29-25.17-184%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GTMUX18.84N/A
N/A
Goldman Sachs Small/Mid Cap Growth R6
SVBCX26.00N/A
N/A
JHancock Balanced C
SHPCX12.06N/A
N/A
Saratoga Health & Biotechnology C
FMEFX32.64N/A
N/A
Nuveen Small/Mid Cap Growth Opp R6
MRGEX19.44N/A
N/A
Morgan Stanley Inst Emerging Mkts IR